Noah Medical develops and sells the Galaxy System, a robotic-assisted bronchoscopy platform combining robotic navigation, integrated imaging, and a single-use bronchoscope for lung diagnosis and biopsy.
Noah Medical is a US maker of the Galaxy robotic bronchoscopy system, which surpassed 5,000 procedures by March 2025, with Galaxy II launched in August 2026. It has published supporting clinical studies (MATCH 2 in March 2026, two CHEST 2025 studies) on a $150M Series B (2023). Revenue is undisclosed (aggregator ARR claims not relied on).
26 signals name Noah Medical. Members see all of them, filtered by topic, source and date.
21 facts on file. Members see all of them with the source link.
Traction: deployment, production, commercials, progress. Capability: technology, positioning, firepower, leverage.
Noah Medical develops and sells the Galaxy System, a robotic-assisted bronchoscopy platform combining robotic navigation, integrated imaging, and a single-use bronchoscope for lung diagnosis and biopsy. Noah Medical is a US maker of the Galaxy robotic bronchoscopy system, which surpassed 5,000 procedures by March 2025, with Galaxy II launched in August 2026. It has published supporting clinical studies (MATCH 2 in March 2026, two CHEST 2025 studies) on a $150M Series B (2023). Revenue is undisclosed (aggregator ARR claims not relied on).
Noah Medical is on the Robotics watchlist list of Frontier Tech Intelligence with a score of 66 out of 100, below the Top 100.
Noah Medical is based in San Carlos, California, United States.
Subscribers see the full file, every signal, the live ranking and the questions the signals answer: where money moved, who controls the layer, where supply is constrained. $99 a month, 7-day trial. What Frontier Tech Intelligence is →